SELLAS Life Sciences
SLS
SLS
29 hedge funds and large institutions have $4.83M invested in SELLAS Life Sciences in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
6.97% less ownership
Funds ownership: 13.99% → 7.02% (-7%)
38% less capital invested
Capital invested by funds: $7.79M → $4.83M (-$2.97M)
Holders
29
Holding in Top 10
–
Calls
$7.45M
Puts
$71K
Top Buyers
| 1 | +$325K | |
| 2 | +$290K | |
| 3 | +$182K | |
| 4 |
BlackRock
New York
|
+$181K |
| 5 |
Millennium Management
New York
|
+$179K |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$25.6K | |
| 3 | -$25K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.9K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$17.6K |